$KTRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kintara Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Kintara Therapeutics, Inc.. Get notifications about new insider transactions in Kintara Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,221 | 11.1 K to 11.2 K (+0.66 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 29,655 | 29.4 K to 29.7 K (+0.72 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | J | 3.20 | 528 | 1,690 | 6,638 | 6.1 K to 6.6 K (+8.64 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 2,415 | 2.3 K to 2.4 K (+3.03 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 885,177 | 885 K to 885.2 K (+0.02 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 49,737 | 49.5 K to 49.7 K (+0.57 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 53,521 | 53.3 K to 53.5 K (+0.33 %) |
| Jun 28 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | P | 3.60 | 4,167 | 15,001 | 29,444 | 25.3 K to 29.4 K (+16.49 %) |
| Jun 28 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | P | 3.60 | 4,167 | 15,001 | 6,110 | 1.9 K to 6.1 K (+214.46 %) |
| Jun 28 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | P | 3.60 | 2,083 | 7,499 | 2,344 | 261 to 2.3 K (+798.08 %) |
| Jun 28 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 3.60 | 4,167 | 15,001 | 49,455 | 45.3 K to 49.5 K (+9.20 %) |
| Jun 28 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 3.60 | 6,700 | 24,120 | 53,345 | 46.6 K to 53.3 K (+14.36 %) |
| Jun 07 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 2.12 | 10,000 | 21,200 | 45,288 | 35.3 K to 45.3 K (+28.34 %) |
| Jun 06 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | P | 2.10 | 9,500 | 19,950 | 25,277 | 15.8 K to 25.3 K (+60.21 %) |
| Jun 06 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 2.12 | 5,000 | 10,600 | 46,645 | 41.6 K to 46.6 K (+12.01 %) |
| May 08 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Chief Executive Off ... | Buy | P | 2.20 | 2,500 | 5,500 | 41,645 | 39.1 K to 41.6 K (+6.39 %) |
| Apr 04 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,147 | 11.1 K to 11.1 K (+0.67 %) |
| Apr 04 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Chief Executive Off ... | Buy | J | 3.20 | 176 | 563 | 39,145 | 39 K to 39.1 K (+0.45 %) |
| Apr 03 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | J | 3.20 | 211 | 675 | 15,777 | 15.6 K to 15.8 K (+1.36 %) |
| Apr 03 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | J | 3.20 | 528 | 1,690 | 1,943 | 1.4 K to 1.9 K (+37.31 %) |
| Apr 03 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 261 | 190 to 261 (+37.37 %) |
| Apr 03 2017 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 885,008 | 884.8 K to 885 K (+0.02 %) |
| Apr 03 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 35,288 | 35 K to 35.3 K (+0.81 %) |
| Feb 22 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | CFO | Option Exercise | A | 4.95 | 37,400 | 185,130 | 37,400 | |
| Feb 22 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Option Exercise | A | 4.95 | 93,600 | 463,320 | 93,600 | |
| Feb 22 2017 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | A | 4.95 | 93,600 | 463,320 | 93,600 | |
| Feb 02 2017 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | C | 1.54 | 125,000 | 192,075 | 0 | |
| Feb 02 2017 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | C | 1.54 | 125,000 | 192,075 | 884,839 | 759.8 K to 884.8 K (+16.45 %) |
| Feb 02 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 5.00 | 4,000 | 20,000 | 38,969 | 35 K to 39 K (+11.44 %) |
| Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 34,969 | 34.8 K to 35 K (+0.51 %) |
| Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 35,006 | 34.7 K to 35 K (+0.81 %) |
| Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 759,839 | 759.7 K to 759.8 K (+0.02 %) |
| Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 190 | 119 to 190 (+59.66 %) |
| Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | J | 3.20 | 528 | 1,690 | 1,415 | 887 to 1.4 K (+59.53 %) |
| Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 15,566 | 15.4 K to 15.6 K (+1.37 %) |
| Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,073 | 11 K to 11.1 K (+0.67 %) |
| Oct 05 2016 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 34,793 | 34.6 K to 34.8 K (+0.51 %) |
| Oct 05 2016 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 119 | 48 to 119 (+147.92 %) |
| Oct 05 2016 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 10,999 | 10.9 K to 11 K (+0.68 %) |
| Oct 05 2016 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 759,670 | 759.5 K to 759.7 K (+0.02 %) |
| Oct 05 2016 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 34,724 | 34.4 K to 34.7 K (+0.82 %) |
| Oct 05 2016 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | J | 3.20 | 528 | 1,690 | 887 | 359 to 887 (+147.08 %) |
| Oct 04 2016 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | J | 3.20 | 211 | 675 | 15,355 | 15.1 K to 15.4 K (+1.39 %) |
| Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 50 | 160 | 10,925 | 10.9 K to 10.9 K (+0.46 %) |
| Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | J | 3.20 | 144 | 461 | 15,144 | 15 K to 15.1 K (+0.96 %) |
| Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | J | 3.20 | 359 | 1,149 | 359 | 0 to 359 |
| Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 48 | 154 | 48 | 0 to 48 |
| Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 115 | 368 | 759,501 | 759.4 K to 759.5 K (+0.02 %) |
| Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 192 | 614 | 34,442 | 34.3 K to 34.4 K (+0.56 %) |
| Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 120 | 384 | 34,617 | 34.5 K to 34.6 K (+0.35 %) |
| May 03 2016 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Option Exercise | P | 0.00 | 3,750 | 0 | 3,750 | |
| May 03 2016 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Option Exercise | P | 0.00 | 9,375 | 0 | 9,375 | |
| May 03 2016 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | P | 0.00 | 3,000 | 0 | 3,000 | |
| May 03 2016 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | P | 0.00 | 1,300 | 0 | 1,300 | |
| May 03 2016 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | P | 0.00 | 1,250 | 0 | 1,250 | |
| May 03 2016 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | P | 0.00 | 5,000 | 0 | 5,000 | |
| May 03 2016 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO, Director | Option Exercise | P | 0.00 | 3,125 | 0 | 3,125 | |
| Nov 30 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO, Director | Buy | P | 1.47 | 7,500 | 11,025 | 137,985 | 130.5 K to 138 K (+5.75 %) |
| Oct 09 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.78 | 200 | 156 | 130,485 | 130.3 K to 130.5 K (+0.15 %) |
| Oct 09 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.80 | 2,800 | 2,240 | 130,285 | 127.5 K to 130.3 K (+2.20 %) |
| Sep 22 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.83 | 4,000 | 3,320 | 127,485 | 123.5 K to 127.5 K (+3.24 %) |
| Jul 28 2015 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | P | 0.75 | 10,000 | 7,500 | 85,000 | |
| Jul 28 2015 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | P | 0.60 | 10,000 | 6,000 | 3,037,542 | 3 M to 3 M (+0.33 %) |
| Jul 28 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Option Exercise | P | 0.75 | 10,000 | 7,500 | 60,000 | |
| Jul 28 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.60 | 10,000 | 6,000 | 123,485 | 113.5 K to 123.5 K (+8.81 %) |
| Jul 23 2015 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | P | 0.75 | 75,000 | 56,250 | 75,000 | |
| Jul 23 2015 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | P | 0.60 | 75,000 | 45,000 | 3,027,542 | 3 M to 3 M (+2.54 %) |
| Jul 17 2015 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | P | 0.75 | 50,000 | 37,500 | 50,000 | |
| Jul 17 2015 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 0.60 | 50,000 | 30,000 | 137,000 | 87 K to 137 K (+57.47 %) |
| Jul 17 2015 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Option Exercise | P | 0.75 | 16,666 | 12,500 | 16,666 | |
| Jul 17 2015 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Buy | P | 0.60 | 16,666 | 10,000 | 2,415,207 | 2.4 M to 2.4 M (+0.69 %) |
| Jul 16 2015 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Option Exercise | P | 0.75 | 50,000 | 37,500 | 50,000 | |
| Jul 16 2015 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | P | 0.60 | 50,000 | 30,000 | 60,000 | 10 K to 60 K (+500.00 %) |
| Jul 16 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Option Exercise | P | 0.75 | 50,000 | 37,500 | 50,000 | |
| Jul 16 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.60 | 50,000 | 30,000 | 113,485 | 63.5 K to 113.5 K (+78.76 %) |
| Jan 22 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Buy | P | 0.65 | 2,500 | 1,625 | 63,485 | 61 K to 63.5 K (+4.10 %) |
| Jan 22 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Buy | P | 0.66 | 5,000 | 3,300 | 60,985 | 56 K to 61 K (+8.93 %) |
| Dec 10 2014 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Buy | P | 0.90 | 2,500 | 2,250 | 55,985 | 53.5 K to 56 K (+4.67 %) |
| Nov 26 2014 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Buy | P | 0.92 | 2,500 | 2,300 | 53,485 | 51 K to 53.5 K (+4.90 %) |
| Nov 24 2014 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 0.95 | 8,000 | 7,600 | 87,000 | 79 K to 87 K (+10.13 %) |
| Oct 31 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Option Exercise | C | 0.00 | 2,388,541 | 0 | 50,000 | |
| Oct 31 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Buy | C | 0.00 | 2,388,541 | 0 | 2,398,541 | 10 K to 2.4 M (+23,885.41 %) |
| Oct 02 2014 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 1.00 | 278,530 | 278,530 | 278,530 | 0 to 278.5 K |
| Sep 19 2014 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Buy | P | 0.98 | 4,000 | 3,920 | 50,985 | 47 K to 51 K (+8.51 %) |
| Sep 16 2014 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Buy | P | 0.75 | 4,985 | 3,739 | 46,985 | 42 K to 47 K (+11.87 %) |
| Sep 10 2014 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 0.71 | 7,000 | 4,970 | 79,000 | 72 K to 79 K (+9.72 %) |
| Sep 05 2014 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 0.78 | 8,000 | 6,237 | 72,000 | 64 K to 72 K (+12.50 %) |
| Apr 24 2014 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 1.25 | 20,000 | 25,000 | 64,000 | 44 K to 64 K (+45.45 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 1.30 | 25,000 | 32,500 | 44,000 | 19 K to 44 K (+131.58 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Buy | P | 1.30 | 10,000 | 13,000 | 42,000 | 32 K to 42 K (+31.25 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Option Exercise | C | 0.00 | 80,000 | 0 | 2,513,541 | |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Sell | S | 1.30 | 10,000 | 13,000 | 10,000 | 20 K to 10 K (-50.00 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Sell | S | 1.30 | 10,000 | 13,000 | 20,000 | 30 K to 20 K (-33.33 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Sell | S | 1.30 | 10,000 | 13,000 | 30,000 | 40 K to 30 K (-25.00 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Sell | S | 1.30 | 25,000 | 32,500 | 40,000 | 65 K to 40 K (-38.46 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Sell | S | 1.30 | 25,000 | 32,500 | 65,000 | 90 K to 65 K (-27.78 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Buy | C | 0.00 | 80,000 | 0 | 90,000 | 10 K to 90 K (+800.00 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | P | 1.30 | 25,000 | 32,500 | 43,500 | 18.5 K to 43.5 K (+135.14 %) |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Praill Scott | CFO | Buy | P | 1.30 | 10,000 | 13,000 | 10,000 | 0 to 10 K |
| Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | P | 1.30 | 10,000 | 13,000 | 2,952,542 | 2.9 M to 3 M (+0.34 %) |
| Mar 04 2014 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | P | 1.56 | 5,000 | 7,808 | 2,942,542 | 2.9 M to 2.9 M (+0.17 %) |
| Feb 21 2014 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and PRESIDENT | Buy | P | 1.00 | 5,000 | 5,000 | 32,000 | 27 K to 32 K (+18.52 %) |
| Feb 12 2014 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | P | 0.83 | 9,000 | 7,504 | 19,000 | 10 K to 19 K (+90.00 %) |
| Feb 13 2014 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and PRESIDENT | Buy | P | 0.80 | 5,000 | 4,000 | 27,000 | 22 K to 27 K (+22.73 %) |
| Feb 07 2014 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | P | 0.88 | 9,000 | 7,920 | 18,500 | 9.5 K to 18.5 K (+94.74 %) |
| Feb 04 2014 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | P | 0.87 | 2,000 | 1,740 | 9,500 | 7.5 K to 9.5 K (+26.67 %) |
| Jan 31 2014 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | P | 0.91 | 7,500 | 6,825 | 7,500 | 0 to 7.5 K |
| Nov 27 2013 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Option Exercise | C | 1.20 | 5,000 | 6,000 | 45,000 | |
| Nov 27 2013 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Buy | C | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Sep 23 2013 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Buy | P | 1.00 | 5,000 | 5,000 | 5,000 | 0 to 5 K |
| Aug 22 2013 | DMPI | DelMar Pharmaceuti ... | Garner William J | Director | Option Exercise | A | 1.05 | 120,000 | 126,000 | 120,000 | |
| Aug 22 2013 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Option Exercise | A | 1.05 | 350,000 | 367,500 | 350,000 | |
| Aug 21 2013 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | C | 0.96 | 10,000 | 9,600 | 90,000 | |
| Aug 21 2013 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 1.05 | 120,000 | 126,000 | 120,000 | |
| Aug 21 2013 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | C | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Aug 20 2013 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | A | 1.05 | 350,000 | 367,500 | 350,000 | |
| Aug 07 2013 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Option Exercise | C | 1.20 | 22,000 | 26,400 | 198,000 | |
| Aug 07 2013 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO and President | Buy | C | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
| Aug 20 2013 | DMPI | DelMar Pharmaceuti ... | Praill Scott | CFO | Option Exercise | A | 1.05 | 350,000 | 367,500 | 350,000 | |
| Aug 06 2013 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | C | 1.20 | 24,000 | 28,800 | 216,000 | |
| Aug 06 2013 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Option Exercise | C | 1.20 | 10,000 | 12,000 | 90,000 | |
| Aug 06 2013 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | C | 0.00 | 34,000 | 0 | 2,937,542 | 2.9 M to 2.9 M (+1.17 %) |